Latest / Health and life sciences

Anthropic buys Mithril Medicine and reports early results with six drug developers

See how this story connects

Anthropic said its life sciences team has run research partnerships with six organisations developing medicines (BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines and The Column Group) and has begun drug discovery of its own. It acquired Mithril Medicine, a one-person company developing treatments for two rare forms of muscular dystrophy, whose founder Cody Tranbarger used Claude to run contracts, logistics and experiments with 11 outside labs and took one candidate from idea to promising results in mice in under 18 months. Among the partner results, Generate scientists used Claude Code to design a part of a CAR T-cell therapy about 70% shorter than the standard version that performed better in lab tests.

Why it matters

Anthropic now runs drug programmes of its own as well as selling Claude to drug makers.

When
27 Oct 2026
ID
WTA-N-2026-0517
Who
Anthropic, Mithril Medicine, Bristol Myers Squibb, Generate Biomedicines; Cody Tranbarger

Summary written with AI by wheresthe.ai, from Anthropic. Checked against the source on 29 Oct 2026.

Source copy: saved on 29 Oct 2026 to check this story and not republished, because the text belongs to its publisher. Document the source offers: document 1 (PDF). Also held by the Internet Archive.

Next stop on this Storyline: Elsewhere: ArmeniaArmenia approves seven-year physical AI programme

Cite this story

WTA-N-2026-0517: “Anthropic buys Mithril Medicine and reports early results with six drug developers.” wheresthe.ai, 27 Oct 2026. https://wheresthe.ai/d/anthropic-acquires-mithril-medicine-drug-programmes-2026-10/ (source: Anthropic).

Spotted an error? Email [email protected].